Out of the night-time and into the day: Ketamine and MDMA as therapies for mental disorders
Open Access
- 27 July 2021
- journal article
- editorial
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 55 (8), 741-743
- https://doi.org/10.1177/00048674211032112
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 studyNature Medicine, 2021
- The Domino Effect: Ed Domino’s early studies of Psychoactive DrugsJournal of Psychoactive Drugs, 2018
- A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant DepressionAmerican Journal of Psychiatry, 2016
- Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. ShulginAddiction, 2010
- Antidepressant effects of ketamine in depressed patientsBiological Psychiatry, 2000